Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Completed 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 14Lymphoid 13Myeloid 9Dermatologic 5Plasma cell 4Classical hematology 4Breast 3Genitourinary 2CNS 2Thoracic 1Sarcoma 1Other solid neoplasm 1

Conditions

Sarcoma 1Retinoblastoma 1Neuroblastoma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Cisplatin 7Pemetrexed 6atezolizumab 5Carboplatin 4tislelizumab 3Paclitaxel 3Leucovorin 3Filgrastim 3Etoposide 3vistusertib 2pembrolizumab 2Vincristine 2Topotecan 2Temozolomide 2Tegafur 2Sorafenib 2Irinotecan 2Immunoenzyme Techniques 2Gemcitabine 2Docetaxel 2Cyclophosphamide 2zirconium-89-trastuzumab 1vandetanib 1toripalimab 1temsirolimus 1tanespimycin 1talazoparib 1soblidotin 1selinexor 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Peripheral Blood Stem Cell Transplantation × Other solid neoplasm × Clear all
NCT00003273 2015-12-03

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NYU Langone Health

Phase 2 Withdrawn
CNSOther solid neoplasmSarcoma

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡